Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands-Reference-Cited by-同舟云学术

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands

Published:2021-05 Issue:5 Volume:24 Page:668-675
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Schneider Paul Peter,Ramaekers Bram L.,Pouwels Xavier,Geurts Sandra,Ibragimova Khava,de Boer Maaike,Vriens Birgit,van de Wouw Yes,den Boer Marien,Pepels Manon,Tjan-Heijnen Vivianne,Joore Manuela

Funder

Wellcome Trust

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference25 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

3. Burden of early, advanced and metastatic breast cancer in The Netherlands;Vondeling;BMC Cancer,2018

4. Economic burden of cancer across the European Union: a population-based cost analysis;Luengo-Fernandez;Lancet Oncol,2013

5. The economic burden of end-of-life care in metastatic breast cancer;Bramley;J Med Econ,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe;European Journal of Cancer;2024-08

2. A retrospective cohort study to evaluate disease burden, health care resource utilization, and costs in patients with breast cancer in Dubai, UAE;BMC Health Services Research;2024-07-12

3. Higher disease burden and lower utilization in mongolian with breast cancer: a 9-year retrospective cohort study of 18.19 million adults in China;International Journal of Surgery;2024-04-11

4. Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer: a register-based comparative study;Scientific Reports;2023-09-28

5. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing;Current Oncology;2023-08-26